{"name":"Azienda Ospedaliera Universitaria Senese","slug":"azienda-ospedaliera-universitaria-senese","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Dolutegravir/lamivudine/abacavir","genericName":"Dolutegravir/lamivudine/abacavir","slug":"dolutegravir-lamivudine-abacavir","indication":"HIV-1 infection in treatment-naïve and treatment-experienced adults","status":"phase_3"}]}],"pipeline":[{"name":"Dolutegravir/lamivudine/abacavir","genericName":"Dolutegravir/lamivudine/abacavir","slug":"dolutegravir-lamivudine-abacavir","phase":"phase_3","mechanism":"This combination of three antiretroviral drugs inhibits HIV replication by blocking integrase and reverse transcriptase enzymes while providing nucleoside backbone coverage.","indications":["HIV-1 infection in treatment-naïve and treatment-experienced adults","HIV-1 infection in adolescents and children (age-appropriate formulations)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxQbVJUcnVYc1V2YnFqWEdIM0JlREVOTmFLU0dzLVZ3d3drTTNKSjYyMDZRYlp4NXdaYkg2NGZzNHdQaDVPUEZmRnFnOTNaSktKZE8zWmZTREJHaG5PM2VOcFN0WWw3d012cm43ancxU3lLaE5JYWtTQTJXY2hPbjZodGhVWjVmMkNvdzJTRW84dnM4UU0?oc=5","date":"2021-06-29","type":"pipeline","source":"Frontiers","summary":"Immunological Events, Emerging Pharmaceutical Treatments and Therapeutic Potential of Balneotherapy on Osteoarthritis - Frontiers","headline":"Immunological Events, Emerging Pharmaceutical Treatments and Therapeutic Potential of Balneotherapy on Osteoarthritis","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}